Pharmacy Drugs
Recent Posts
- Malignant Brain Tumors: Chemotherapy Alone Is Just As Effective As Radiation / New Positive Prognostic Factor Found
- Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference
- Intercept Pharmaceuticals’ FXR Agonist INT-747 Meets Primary Endpoint In A Phase II Clinical Trial In Type 2 Diabetic Patients
- Largest Clinical Trial To Test Benefits Of Aspirin In Australia
- University Of Florida To Receive $29.5 Million In Recovery Act Funds To Begin Study Of Whether Exercise Prevents Disability In Older Adults
Random Posts
- No New Year's Joy from FDA
- Women With Breast Cancer Cope Better Following Program Focused On Body, Mind And Spirit
- Young Adults Who Exercise Get Higher IQ
- EyeGate Pharma Completes Phase II Study Of EGP-437 In Patients With Anterior Uveitis
- Nuclear Medicine And Molecular Imaging Professionals Will Convene In Albuquerque, N.M., Jan. 27-Feb. 2010
- Can-Fite BioPharma To Initiate Phase II Clinical Trial With CF101 For The Treatment Of Glaucoma
- Trained And Certified Blinded Readers Help ICON Medical Imaging Complete Oncology Trial Ahead Of Schedule
- NACDS To Honor Len DeMino At NACDS Pharmacy & Technology Conference As Industry Icon Announces Retirement As Consultant To The Association
- Shire Selects SAS(R) Drug Development To Handle Clinical Trials Data
- Member Support Helps Breakthrough In Decriminalisation Of Dispensing Errors Campaign
Mo. House Approves Amendment Allowing Pharmacies To Refuse To Stock EC, Medication Abortion Drugs
Posted by: admin in Pharmacy, Pharmacy Drugs on May 03rd, 2009
The Missouri House on Tuesday voted 115-43 to approve an amendment that would allow pharmacies to refuse to dispense emergency contraception or fill prescriptions, the Columbia Missourian reports. According to the Missourian, the bill specifically mentions the emergency contraceptive Plan B, which can prevent pregnancy if taken within 72 hours of sexual intercourse, and mifepristone, which is available by prescription only and used to induce abortion. Mifepristone is only available through a doctor and cannot be distributed by a pharmacy according to the Missourian.
The amendment, sponsored by state Rep. Ed Emery (R), prohibits lawsuits against pharmacies that do not carry the drugs and prevents the state from revoking the licenses of pharmacies that do not supply the medications. FDA recently announced that it would allow individuals ages 17 and older to purchase Plan B without a prescription (Wire, Columbia Missourian, 4/28). In addition, the amendment stipulates that pharmacies would not be required to advise people on how to obtain the medications. Current Missouri law does not address whether pharmacies must stock the drugs. According to the AP/Springfield News-Leader, Missouri’s Senate already approved the original bill (S.B 296), which involves professional licensing regulations.
Many Democrats objected to Emery’s amendment, arguing that the measure could hinder women’s access to EC, especially for women in rural areas (Blank, AP/Springfield News-Leader, 4/28). Some Democrats also said that the amendment is an attempt to control women’s bodies. “To implement a law like this, especially in a rural area, seems to me to put another road block before women,” state Rep. Mary Still (D) said. According to Emery, the measure is needed to protect pharmacy owners who object to stocking EC and mifepristone (Columbia Missourian, 4/28).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women’s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women’s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.